Clinical Chemistry · 1997 · 18 citations · 61 references
MedicineOncologyPathologyEndocrine OncologyHormone BiochemistrySteroid BiochemistryBreast CytologyEndocrine Tumor PathologyHormone-secreting TumorsTumor AntigensTumor MarkersTumor-associated AntigensNeoplastic DiseaseProgesterone ReceptorsReceptors
A case is presented of female breast intracystic carcinoma with prostate-specific antigen (PSA) expressed in high amounts in aspirated cystic fluid (55 micrograms/L). Tumor extract analysis revealed the presence of both estrogen and progesterone receptors (0.38 and 1.87 nmol/L, respectively) and high quantities of PSA too (19.52 micrograms/L). Chromatographic analysis of cystic fluid revealed two peaks of PSA, at the expected positions for free and bound serine protease. A major proportion of 33-kDa free from was also confirmed by Western blotting analysis. Free PSA was heat-stable at 56 degrees C and displayed no change after freezing-thawing. These findings are discussed in the context of a detailed literature survey. Our data support the contention that PSA immunoreactivity in intracystic fluid of breast carcinoma is partly the result of secretory activity by the neoplastic cells and that the steroid receptors can also modulate its expression.
61
Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases
D J Grignon, Jae Y. Ro, Alberto G. Ayala et al. · Cancer · 1991 · 325 citations · Full text
Kim Pettersson, Timo Piironen, M Seppälä et al. · Clinical Chemistry · 1995 · 192 citations